作者
- Bhatt, D.L. (17)
- Califf, R.M. (64)
- Ellis, S.G. (27)
- Granger, C.B. (22)
- Harrington, R.A. (16)
- Kleiman, N.S. (17)
- Lincoff, A.M. (21)
- Moliterno, D.J. (16)
- Topol, E.J. (170)
- White, H.D. (22)
|
總筆數:170
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Proteinuria is a key determinant of death in patients with diabetes afterisolated coronary artery bypass grafting |
Marso, S.P.;Ellis, S.G.;Gurm, H.S.;Lytle, B.W.;Topol, E.J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to AvoidVascular Occlusion (BRAVO) trial |
Topol, E.J.;Easton, J.;Amarenco, P.;Califf, R.;Harrington, R.;Graffagnino, C.;Davis, S.;Diener, H.C.;Ferguson, J.;Fitzgerald, D.;Shuaib, A.;Koudstaal, P.J.;Theroux, P.;Van de Werf, F.;Willerson, J.T.;Chan, R.;Samuels, R.;Ilson, B.;Granett, J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Proteinuria is a key determinant of death in patients with diabetesafter isolated coronary artery bypass grafting |
Marso, S.P.;Ellis, S.G.;Gurm, H.S.;Lytle, B.W.;Topol, E.J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Hierarchy of risk based on history and location of prior myocardialinfarction in the thrombolytic era |
Brieger, D.B.;Mak, K.-H.;Miller, D.P.;Califf, R.M.;Topol, E.J.;for the GUSTO-I Investigators; |
American Heart Journal |
2000-07-01 |
查看 |
| Reduction in the need for hospitalization for recurrent ischemic events andbleeding with clopidogrel instead of aspirin |
Bhatt, D.L.;Hirsch, A.T.;Ringleb, P.A.;Hacke, W.;Topol, E.J.;on behalf of the CAPRIE investigators; |
American Heart Journal |
2000-07-01 |
查看 |
| Clinical correlates and course of thrombocytopenia during percutaneouscoronary intervention in the era of abciximab platelet glycoproteinIIb/IIIa blockade |
Kereiakes, D.J.;Berkowitz, S.D.;Lincoff, A.M.;Tcheng, J.E.;Wolski, K.;Achenbach, R.;Melsheimer, R.;Anderson, K.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
2000-07-01 |
查看 |
| Hierarchy of risk based on history and location of prior myocardialinfarction in the thrombolytic era |
Brieger, D.B.;Mak, K.-H.;Miller, D.P.;Califf, R.M.;Topol, E.J.;for the GUSTO-I Investigators; |
American Heart Journal |
2000-07-01 |
查看 |
| Reduction in the need for hospitalization for recurrent ischemic events andbleeding with clopidogrel instead of aspirin |
Bhatt, D.L.;Hirsch, A.T.;Ringleb, P.A.;Hacke, W.;Topol, E.J.;on behalf of the CAPRIE investigators; |
American Heart Journal |
2000-07-01 |
查看 |
| Clinical correlates and course of thrombocytopenia during percutaneouscoronary intervention in the era of abciximab platelet glycoproteinIIb/IIIa blockade |
Kereiakes, D.J.;Berkowitz, S.D.;Lincoff, A.M.;Tcheng, J.E.;Wolski, K.;Achenbach, R.;Melsheimer, R.;Anderson, K.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
2000-07-01 |
查看 |
| Negative T waves shortly after ST-elevation acute myocardial infarction area powerful marker for improved survival rate |
Sgarbossa, E.B.;Meyer, P.M.;Pinski, S.L.;Pavlovic-Surjancev, B.;Barbagelata, A.;Goodman, S.G.;Lum, A.S.;Underwood, D.A.;Gates^e, K.B.;Califf, R.M.;Topol, E.J.;Wagner, G.S.; |
American Heart Journal |
2000-09-01 |
查看 |
| Negative T waves shortly after ST-elevation acute myocardial infarction area powerful marker for improved survival rate |
Sgarbossa, E.B.;Meyer, P.M.;Pinski, S.L.;Pavlovic-Surjancev, B.;Barbagelata, A.;Goodman, S.G.;Lum, A.S.;Underwood, D.A.;Gates^e, K.B.;Califf, R.M.;Topol, E.J.;Wagner, G.S.; |
American Heart Journal |
2000-09-01 |
查看 |
| Negative T waves shortly after ST-elevation acute myocardial infarctionare a powerful marker for improved survival rate |
Sgarbossa, E.B.;Meyer, P.M.;Pinski, S.L.;Pavlovic-Surjancev, B.;Barbagelata, A.;Goodman, S.G.;Lum, A.S.;Underwood, D.A.;Gates, K.B.;Califf, R.M.;Topol, E.J.;Wagner, G.S.; |
American Heart Journal |
2000-09-01 |
查看 |
| A direct comparison of tirofiban and abciximab during percutaneous coronaryrevascularization and stent placement: Rationale and design of the TARGETstudy |
Moliterno, D.J.;Topol, E.J.;for the TARGET International Steering Committee*; |
American Heart Journal |
2000-11-01 |
查看 |
| A direct comparison of tirofiban and abciximab during percutaneous coronaryrevascularization and stent placement: Rationale and design of the TARGETstudy |
Moliterno, D.J.;Topol, E.J.;for the TARGET International Steering Committee*; |
American Heart Journal |
2000-11-01 |
查看 |
| Introduction |
Kereiakes, D.J.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Importance of microembolization and inflammation in atherosclerotic heartdisease |
Yamada, D.M.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Introduction |
Kereiakes, D.J.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Importance of microembolization and inflammation in atherosclerotic heartdisease |
Yamada, D.M.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
Wong, C.-K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.M.;for the GUSTO-III Investigators; |
American Heart Journal |
2000-12-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
Wong, C.K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.;for the GUSTO-III Investigators; |
American Heart Journal |
2000-12-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
for the GUSTO-III Investigators;Wong, C.K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.; |
American Heart Journal |
2000-12-01 |
查看 |
| Introduction |
Kereiakes, D.J.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Introduction |
Kereiakes, D.J.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Importance of microembolization and inflammation in atheroscleroticheart disease |
Yamada, D.M.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Importance of microembolization and inflammation in atheroscleroticheart disease |
Yamada, D.M.;Topol, E.J.; |
American Heart Journal |
2000-12-01 |
查看 |
| Outcome of acute ST-segment elevation myocardial infarction in patientswith prior coronary artery bypass surgery receiving thrombolytic therapy |
Labinaz, M.;Sketch, M.H.;Ellis, S.G.;Abramowitz, B.M.;Stebbins, A.L.;Pieper, K.S.;Holmes, D.R.;Califf, R.M.;Topol, E.J.;for the GUSTO-I Investigators; |
American Heart Journal |
2001-03-01 |
查看 |
| Variation in patient management and outcomes for acute coronary syndromesin Latin America and North America: Results from the Platelet IIb/IIIa inUnstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT)trial |
Cohen, M.G.;Pacchiana, C.M.;Corbalan, R.;Isea Perez, J.E.;Ponte, C.I.;Oropeza, E.S.;Diaz, R.;Paolasso, E.;Izasa, D.;Rodas, M.A.;Urrutia, C.E.;Harrington, R.A.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
2001-03-01 |
查看 |
| Variation in patient management and outcomes for acute coronary syndromesin Latin America and North America: Results from the Platelet IIb/IIIa inUnstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT)trial |
Cohen, M.G.;Pacchiana, C.M.;Corbalan, R.;Isea Perez, J.E.;Ponte, C.I.;Oropeza, E.S.;Diaz, R.;Paolasso, E.;Izasa, D.;Rodas, M.A.;Urrutia, C.E.;Harrington, R.A.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
2001-03-01 |
查看 |
| Outcome of acute ST-segment elevation myocardial infarction in patientswith prior coronary artery bypass surgery receiving thrombolytic therapy |
Labinaz, M.;Sketch, M.H.;Ellis, S.G.;Abramowitz, B.M.;Stebbins, A.L.;Pieper, K.S.;Holmes, D.R.;Califf, R.M.;Topol, E.J.;for the GUSTO-I Investigators; |
American Heart Journal |
2001-03-01 |
查看 |
| Variation in patient management and outcomes for acute coronary syndromesin Latin America and North America: Results from the Platelet IIb/IIIa inUnstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT)trial |
Cohen, M.G.;Pacchiana, C.M.;Corbalan, R.;Isea Perez, J.E.;Ponte, C.I.;Oropeza, E.S.;Diaz, R.;Paolasso, E.;Izasa, D.;Rodas, M.A.;Urrutia, C.E.;Harrington, R.A.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
2001-03-01 |
查看 |
| Outcome of acute ST-segment elevation myocardial infarction in patientswith prior coronary artery bypass surgery receiving thrombolytic therapy |
Labinaz, M.;Sketch, M.H.;Ellis, S.G.;Abramowitz, B.M.;Stebbins, A.L.;Pieper, K.S.;Holmes, D.R.;Califf, R.M.;Topol, E.J.;for the GUSTO-I Investigators; |
American Heart Journal |
2001-03-01 |
查看 |
| Recurrent ischemia after thrombolysis for acute myocardial infarction |
Pilote, L.;Miller, D.P.;Califf, R.M.;Topol, E.J.;for the Global Utilization of Streptokinase and Tissue Plasminogen;Activator for Occluded Coronary Arteries (GUSTO-I) Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Effect of smoking status and abciximab use on outcome after percutaneouscoronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT |
Cho, L.;Bhatt, D.L.;Wolski, K.;Lincoff, M.;Topol, E.J.;Moliterno, D.J.; |
American Heart Journal |
2001-04-01 |
查看 |
| Recurrent ischemia after thrombolysis for acute myocardial infarction |
Pilote, L.;Miller, D.P.;Califf, R.M.;Topol, E.J.;for the Global Utilization of Streptokinase and Tissue Plasminogen;Activator for Occluded Coronary Arteries (GUSTO-I) Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Effect of smoking status and abciximab use on outcome after percutaneouscoronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT |
Cho, L.;Bhatt, D.L.;Wolski, K.;Lincoff, M.;Topol, E.J.;Moliterno, D.J.; |
American Heart Journal |
2001-04-01 |
查看 |
| Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment, patency, and body mass index |
Lundergan, C.F.;Ross, A.M.;McCarthy, W.F.;Reiner, J.S.;Boyle, D.;Fink, C.;Califf, R.M.;Topol, E.J.;Simoons, M.L.;Van Den Brand, M.;Van de Werf, F.;Coyne, K.S.;for the GUSTO-I Angiographic Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| Predictors of left ventricular function after acute myocardialinfarction: Effects of time to treatment, patency, and body mass index |
Lundergan, C.F.;Ross, A.M.;McCarthy, W.F.;Reiner, J.S.;Boyle, D.;Fink, C.;Califf, R.M.;Topol, E.J.;Simoons, M.L.;Van Den Brand, M.;Van de Werf, F.;Coyne, K.S.;for the GUSTO-I Angiographic Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| Bivalirudin versus heparin during coronary angioplasty for unstable orpostinfarction angina: Final report reanalysis of the BivalirudinAngioplasty Study |
Bittl, J.A.;Chaitman, B.R.;Feit, F.;Kimball, W.;Topol, E.J.;on behalf of the Bivalirudin Angioplasty Study Investigators; |
American Heart Journal |
2001-12-01 |
查看 |
| Bivalirudin versus heparin during coronary angioplasty for unstable orpostinfarction angina: Final report reanalysis of the BivalirudinAngioplasty Study |
Bittl, J.A.;Chaitman, B.R.;Feit, F.;Kimball, W.;Topol, E.J.;on behalf of the Bivalirudin Angioplasty Study Investigators; |
American Heart Journal |
2001-12-01 |
查看 |
| Bivalirudin versus heparin during coronary angioplasty for unstable orpostinfarction angina: Final report reanalysis of the BivalirudinAngioplasty Study |
on behalf of the Bivalirudin Angioplasty Study Investigators;Bittl, J.A.;Chaitman, B.R.;Feit, F.;Kimball, W.;Topol, E.J.; |
American Heart Journal |
2001-12-01 |
查看 |
| Misreporting of myocardial infarction end points: Results of adjudicationby a central clinical events committee in the PARAGON-B trial |
Mahaffey, K.W.;Roe, M.T.;Dyke, C.K.;Newby, L.K.;Kleiman, N.S.;Connolly, P.;Berdan, L.G.;Sparapani, R.;Lee, K.L.;Armstrong, P.W.;Topol, E.J.;Califf, R.M.;Harrington, R.A.;for the PARAGON-B Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Misreporting of myocardial infarction end points: Results ofadjudication by a central clinical events committee in the PARAGON-B trial |
Mahaffey, K.W.;Roe, M.T.;Dyke, C.K.;Newby, L.;Kleiman, N.S.;Connolly, P.;Berdan, L.G.;Sparapani, R.;Lee, K.L.;Armstrong, P.W.;Topol, E.J.;Califf, R.M.;Harrington, R.A.;for the PARAGON-B Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural riskassessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor forstenting trial and implication for ad hoc use of glycoprotein IIb-IIIaantagonists |
Mazur, W.;Kaluza, G.L.;Sapp, S.;Balog, C.;Topol, E.J.;Mark, D.B.;Ellis, S.G.;Kereiakes, D.J.;Lincoff, A.M.;Kleiman, N.S.; |
American Heart Journal |
2002-04-01 |
查看 |
| Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural riskassessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor forstenting trial and implication for ad hoc use of glycoprotein IIb-IIIaantagonists |
Mazur, W.;Kaluza, G.L.;Sapp, S.;Balog, C.;Topol, E.J.;Mark, D.B.;Ellis, S.G.;Kereiakes, D.J.;Lincoff, A.;Kleiman, N.S.; |
American Heart Journal |
2002-04-01 |
查看 |
| Bivalirudin with planned or provisional abciximab versus low-dose heparinand abciximab during percutaneous coronary revascularization: Results ofthe Comparison of Abciximab Complications with Hirulog for Ischemic EventsTrial (CACHET) |
Lincoff, A.M.;Kleiman, N.S.;Kottke-Marchant, K.;Maierson, E.S.;Maresh, K.;Wolski, K.E.;Topol, E.J.; |
American Heart Journal |
2002-05-01 |
查看 |
| Bivalirudin with planned or provisional abciximab versus low-dose heparinand abciximab during percutaneous coronary revascularization: Results ofthe Comparison of Abciximab Complications with Hirulog for Ischemic EventsTrial (CACHET) |
Lincoff, A.M.;Kleiman, N.S.;Kottke-Marchant, K.;Maierson, E.S.;Maresh, K.;Wolski, K.E.;Topol, E.J.; |
American Heart Journal |
2002-05-01 |
查看 |
| Bivalirudin with planned or provisional abciximab versus low-doseheparin and abciximab during percutaneous coronary revascularization:Results of the Comparison of Abciximab Complications with Hirulog forIschemic Events Trial (CACHET) |
Lincoff, A.;Kleiman, N.S.;Kottke-Marchant, K.;Maierson, E.S.;Maresh, K.;Wolski, K.E.;Topol, E.J.; |
American Heart Journal |
2002-05-01 |
查看 |
| Bivalirudin with planned or provisional abciximab versus low-doseheparin and abciximab during percutaneous coronary revascularization:Results of the Comparison of Abciximab Complications with Hirulog forIschemic Events Trial (CACHET) |
Lincoff, A.;Kleiman, N.S.;Kottke-Marchant, K.;Maierson, E.S.;Maresh, K.;Wolski, K.E.;Topol, E.J.; |
American Heart Journal |
2002-05-01 |
查看 |
| Prognostic significance of creatine kinase-MB elevation after percutaneouscoronary intervention in patients with chronic renal dysfunction |
Jeremias, A.;Albirini, A.;Ziada, K.M.;Chew, D.P.;Brener, S.J.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
2002-06-01 |
查看 |
| Prognostic significance of creatine kinase-MB elevation afterpercutaneous coronary intervention in patients with chronic renaldysfunction |
Jeremias, A.;Albirini, A.;Ziada, K.M.;Chew, D.P.;Brener, S.J.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
2002-06-01 |
查看 |
| Prognostic significance of creatine kinase-MB elevation afterpercutaneous coronary intervention in patients with chronic renaldysfunction |
Jeremias, A.;Albirini, A.;Ziada, K.M.;Chew, D.P.;Brener, S.J.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
2002-06-01 |
查看 |
| Prognostic significance of creatine kinase-MB elevation afterpercutaneous coronary intervention in patients with chronic renaldysfunction |
Jeremias, A.;Albirini, A.;Ziada, K.M.;Chew, D.P.;Brener, S.J.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
2002-06-01 |
查看 |
|
|
|
